Cargando…
Enhanced anti-tumor activity and cytotoxic effect on cancer stem cell population of metformin-butyrate compared with metformin HCl in breast cancer
Metformin, which is a drug commonly used to treat type 2 diabetes, has shown anti-tumor effects in numerous experimental, epidemiologic, observational, and clinical studies. Here, we report a new metformin derivative, metformin-butyrate (MFB). Compared to metformin-HCl, it more potently activates AM...
Autores principales: | Lee, Kyung-Min, Lee, Minju, Lee, Jiwoo, Kim, Sung Wuk, Moon, Hyeong-Gon, Noh, Dong-Young, Han, Wonshik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5122406/ https://www.ncbi.nlm.nih.gov/pubmed/27223262 http://dx.doi.org/10.18632/oncotarget.9522 |
Ejemplares similares
-
Correction: Enhanced anti-tumor activity and cytotoxic effect on cancer stem cell population of metformin-butyrate compared with metformin HCl in breast cancer
por: Lee, Kyung-Min, et al.
Publicado: (2021) -
Association of Insulin, Metformin, and Statin with Mortality in Breast Cancer Patients
por: Choi, Mihong, et al.
Publicado: (2021) -
Transition into inflammatory cancer-associated adipocytes in breast cancer microenvironment requires microRNA regulatory mechanism
por: Lee, Jiwoo, et al.
Publicado: (2017) -
The Clinical Significance and Molecular Features of the Spatial Tumor Shapes in Breast Cancers
por: Moon, Hyeong-Gon, et al.
Publicado: (2015) -
Gamma scintigraphic study of the hydrodynamically balanced matrix tablets of Metformin HCl in rabbits
por: Razavi, Mahboubeh, et al.
Publicado: (2015)